Здоровье
Индия расширяет расследование по поводу специй из-за опасений по поводу загрязнения
India’s food safety regulator said on Thursday it had ordered testing and inspections of all companies making spice blends, widening investigations into the sector as
J&J выделила $6,48 млрд на урегулирование исков о раке, вызванных тальком
Johnson & Johnson said Wednesday it is moving forward with a $6.48 billion settlement offer for tens of thousands of lawsuits alleging that its baby
Цены на Wegovy и Ozempic в США упали в первом квартале
Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and
Рождаемость в США снижается после роста в эпоху пандемии
The number of births in the US in 2023 fell by 2% from the previous year, thanks in part to a sharp decline in births
Шольц обещает поддержать фармацевтический сектор Германии инвестициями Merck
German Chancellor Olaf Scholz said at a ceremony with Merck to support the pharmaceutical sector by providing tax breaks for research and cutting red tape
Два миллиона британцев страдают длительными симптомами COVID
Two million people in England and Scotland continue to suffer from prolonged symptoms of COVID, of whom 381,000 have had their daily activities severely limited,
ЕС начинает расследование на китайском рынке медицинского оборудования
The European Commission on Wednesday launched an investigation into China’s state purchases of medical equipment, the latest in a series of moves that are heightening
Республика Конго объявила эпидемию мпоксита
The Republic of Congo has declared a Congo smallpox epidemic after 19 cases were confirmed in five departments. No deaths have yet been reported, said
Около 3,6 миллиона бенефициаров Medicare могут иметь право на страховое покрытие Wegovy
About 3.6 million overweight or obese patients with cardiovascular disease insured under Medicare in the U.S. may be eligible for coverage of Novo Nordisk’s weight-loss
FDA отказывается одобрить лечение кожных заболеваний
Abeona Therapeutics said on Monday that the US Food and Drug Administration (FDA) refused to approve the treatment for a rare skin blister, causing its